A Pharmacokinetic Study of DW6013 (FDC of Linagliptin and Metformin) in Healthy Adult Volunteers
Status:
Completed
Trial end date:
2022-10-11
Target enrollment:
Participant gender:
Summary
This study is to compare and evaluate the safety and pharmacokinetic characteristics (PK)
after administration of DW6013 and each component in healthy adult volunteers in fast
condition.